Italy · Delayed Price · Currency is EUR DiaSorin Statistics
Total Valuation
DiaSorin has a market cap or net worth of EUR 3.90 billion. The enterprise value is 4.74 billion.
| Market Cap | 3.90B |
| Enterprise Value | 4.74B |
Important Dates
The next confirmed earnings date is Friday, November 6, 2026.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | May 18, 2026 |
Share Statistics
DiaSorin has 49.50 million shares outstanding. The number of shares has decreased by -5.80% in one year.
| Current Share Class | 49.50M |
| Shares Outstanding | 49.50M |
| Shares Change (YoY) | -5.80% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 14.30% |
| Owned by Institutions (%) | 11.70% |
| Float | 14.96M |
Valuation Ratios
The trailing PE ratio is 29.29 and the forward PE ratio is 19.37. DiaSorin's PEG ratio is 2.52.
| PE Ratio | 29.29 |
| Forward PE | 19.37 |
| PS Ratio | 3.31 |
| PB Ratio | 2.76 |
| P/TBV Ratio | 158.23 |
| P/FCF Ratio | 16.40 |
| P/OCF Ratio | 12.70 |
| PEG Ratio | 2.52 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.37, with an EV/FCF ratio of 19.91.
| EV / Earnings | 33.70 |
| EV / Sales | 4.02 |
| EV / EBITDA | 13.37 |
| EV / EBIT | 18.61 |
| EV / FCF | 19.91 |
Financial Position
The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.68.
| Current Ratio | 1.79 |
| Quick Ratio | 0.85 |
| Debt / Equity | 0.68 |
| Debt / EBITDA | 2.72 |
| Debt / FCF | 4.06 |
| Interest Coverage | 9.10 |
Financial Efficiency
Return on equity (ROE) is 9.16% and return on invested capital (ROIC) is 8.03%.
| Return on Equity (ROE) | 9.16% |
| Return on Assets (ROA) | 5.52% |
| Return on Invested Capital (ROIC) | 8.03% |
| Return on Capital Employed (ROCE) | 10.29% |
| Weighted Average Cost of Capital (WACC) | 6.89% |
| Revenue Per Employee | 361,165 |
| Profits Per Employee | 43,120 |
| Employee Count | 3,260 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 1.20 |
Taxes
In the past 12 months, DiaSorin has paid 56.61 million in taxes.
| Income Tax | 56.61M |
| Effective Tax Rate | 29.54% |
Stock Price Statistics
The stock price has increased by +3.09% in the last 52 weeks. The beta is 0.70, so DiaSorin's price volatility has been lower than the market average.
| Beta (5Y) | 0.70 |
| 52-Week Price Change | +3.09% |
| 50-Day Moving Average | 74.11 |
| 200-Day Moving Average | 68.95 |
| Relative Strength Index (RSI) | 64.96 |
| Average Volume (20 Days) | 214,560 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DiaSorin had revenue of EUR 1.18 billion and earned 140.57 million in profits. Earnings per share was 2.69.
| Revenue | 1.18B |
| Gross Profit | 759.78M |
| Operating Income | 254.55M |
| Pretax Income | 191.67M |
| Net Income | 140.57M |
| EBITDA | 341.90M |
| EBIT | 254.55M |
| Earnings Per Share (EPS) | 2.69 |
Balance Sheet
The company has 120.88 million in cash and 965.25 million in debt, with a net cash position of -844.38 million or -17.06 per share.
| Cash & Cash Equivalents | 120.88M |
| Total Debt | 965.25M |
| Net Cash | -844.38M |
| Net Cash Per Share | -17.06 |
| Equity (Book Value) | 1.42B |
| Book Value Per Share | 28.76 |
| Working Capital | 331.65M |
Cash Flow
In the last 12 months, operating cash flow was 307.03 million and capital expenditures -69.13 million, giving a free cash flow of 237.90 million.
| Operating Cash Flow | 307.03M |
| Capital Expenditures | -69.13M |
| Depreciation & Amortization | 87.35M |
| Net Borrowing | 168.03M |
| Free Cash Flow | 237.90M |
| FCF Per Share | 4.81 |
Margins
Gross margin is 64.53%, with operating and profit margins of 21.62% and 11.94%.
| Gross Margin | 64.53% |
| Operating Margin | 21.62% |
| Pretax Margin | 16.28% |
| Profit Margin | 11.94% |
| EBITDA Margin | 29.04% |
| EBIT Margin | 21.62% |
| FCF Margin | 20.21% |
Dividends & Yields
This stock pays an annual dividend of 1.30, which amounts to a dividend yield of 1.65%.
| Dividend Per Share | 1.30 |
| Dividend Yield | 1.65% |
| Dividend Growth (YoY) | 8.33% |
| Years of Dividend Growth | 6 |
| Payout Ratio | 46.41% |
| FCF Payout Ratio | 27.05% |
| Buyback Yield | 5.80% |
| Shareholder Yield | 7.45% |
| Earnings Yield | 3.60% |
| FCF Yield | 6.10% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for DiaSorin is 72.81, which is -7.60% lower than the current price. The consensus rating is "Hold".
| Price Target | 72.81 |
| Price Target Difference | -7.60% |
| Analyst Consensus | Hold |
| Analyst Count | 14 |
| Revenue Growth Forecast (3Y) | 5.11% |
| EPS Growth Forecast (3Y) | 3.69% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
DiaSorin has an Altman Z-Score of 3.5 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.5 |
| Piotroski F-Score | 6 |